A protein's life inside a cell is usually terminated by the action of proteases that hydrolyse the polypeptide to small peptides or free amino acids. Many proteolytic enzymes are specific for only a few protein substrates, or they mediate highly specialized functions. Promiscuous proteases with broad specificities, however, are generally sequestered and reside within specialized organelles known as lysosomes or vacuoles. Such compartmentalization is vital, as constitutively active, free proteases with broad specificities would be disastrous for proteinaceous cellular companions.
The ubiquitin/proteasome system stands out from the nonlysosomal proteolytic systems because it has the capacity to degrade almost any protein but generally remains a harmless neighbor of intracellular proteins. A number of exciting discoveries in various fields have finally brought this system into the limelight (reviewed by Ciechanover, 1994; Hochstrasser, 1995) . Ubiquitin/proteasome-mediated degradation was recently found to be instrumental in the regulation of a wealth of diverse cellular functions, such as DNA repair, cell cycle progression, signal transduction, transcription, and antigen presentation. A major clue as to how this degradation system operates came from the recently reported crystal structure of the proteasome (L0we et al., 1995) . Several implications of these findings will be addressed below.
Protein Targeting
The lifespan of intracellular proteins can differ by several orders of magnitude. Structural proteins or proteins that are constitutively required are usually long-lived. In contrast, key regulatory proteins are often rapidly degraded.
Their degradation, which can be precisely timed and regulated, offers the possibility of an instant switch from one functional cellular program to another. Recent examples of regulatory proteins that are turned over by the ubiquitin/ proteasome pathway are the transcription factors MAT~2 and GCN4 from yeast, the c-jun gene product, a segment of the precursor of the p50 subunit of NF-KB, IKB, the tumor suppressor protein p53, the Mos kinase, cyclins, inhibitors of cyclin-dependent kinases, and the ~ subunit of a trimeric G protein (reviewed by Jentsch, 1992; Ciechanover, 1994; Hochstrasser, 1995) . Moreover, the ubiquitin/proteasome system also detects and eliminates abnormal proteins such as misfolded proteins or proteins that would otherwise be part of a larger complex but fail to find their partners.
The challenge for this pathway is to identify and destroy from a large pool of proteins only those whose degradation is desired. Proteins are assumed to bear specific degradation signals analogous to those that target proteins to certain organelles or compartments. However, proteolytic signals are expected to be more complex in their organization and sequence diversity than targeting signals because they should indicate not only whether the protein has to be degraded, but also at what rate and when. To decode each of these putative signals, nature has evolved a specialized recognition and targeting apparatus, the ubiquitin-conjugation system (reviewed by Jentsch, 1992) . This system seems to operate functionally and spatially detached from the protease, the proteasome, in both the cytosol and the nucleus of eukaryotic cells. Recognized substrates are earmarked by the covalent attachment of ubiquitin, a small and highly stable protein. Ubiquitin linked via its carboxyl terminus to internal lysine residues of the substrates seems to act, at least in part, as a sorting signal, targeting conjugates to the proteasome. In most cases several ubiquitin molecules are added to the substrate as a multiubiquitin chain in which ubiquitin molecules are arranged like beads on a string. Multiubiquitinated proteins are apparently preferred by the proteasome.
Conjugation of ubiquitin to substrate proteins requires a reaction cascade (Jentsch, 1992; Scheffner et al., 1995) . Initially, ubiquitin-activating (El) enzyme hydrolyses ATP and forms a thioester bond between itself and ubiquitin. Ubiquitin is then passed on to ubiquitin-conjugating (E2) enzymes and often subsequently to ubiquitin ligases (E3). Conjugation of ubiquitin to substrate proteins is thought to be catalyzed by either E2 alone or by a combination of E2 with E3. Interestingly, both E2 and E3 proteins exist as large families, and members of each family seem to differ in their properties and intracellular localization. Indeed, mutations in individual genes for different yeast E2 enzymes revealed that these enzymes are involved in distinct processes such as DNA repair, cell cycle progression, peroxisome biogenesis, heat shock resistance, and cadmium tolerance (Jentsch, 1992; Seufert et al., 1995) . At least some E2 enzymes can form heterodimers with each other, and it is assumed that diverse combinations of E2s with different E3 proteins is likely to define the large repertoire of substrate specificities.
Proteasome: Form Follows Function
Proteins tagged with multiubiquitin chains are degraded by the proteasome, yielding small peptides in a reaction that requires ATP. Proteasomes are abundant (up to 1% of cellular protein) multisubunit particles (reviewed by Peters, 1994) . In eukaryotes they reside in the cytosol and the nucleus, but are apparently absent from other cellular compartments. Proteasomes can be isolated as particles with sedimentation coefficients of 20S and 26S; the 20S particle represents the proteolytically active core of the larger particle. It is unclear whether free 20S particles exist in a cell and display biological activity or whether they are simply a consequence of the fractionation procedure. 20S proteasomes with virtually indistinguishable basic struc-tural features can be purified from all eukaryotes, archaebacteria, and (as shown recently) even some eubacteria (Tamura et al., 1995) , indicating that they are common to many forms of life. The 20S core particle is barrel shaped, with four stacked rings each comprising seven polypeptides. The prototype is represented by the proteasome from the archaebacterium Thermoplasma, which is as, sembled from two different but related proteins called c( and 13. The rings at both ends of the proteasome cylinder are formed by ~ subunits and the two central rings by 13 subunits, resulting in a stoichiometry of (~7137137(~. 20S proteasomes from eukaryotes have shown a more complex organization as families of (~-and 13-related proteins have evolved. In yeast seven genes for (~-Iike and seven genes for 13-like subunits have been identified, and all 14 gene products are apparently assembled into the same 20S particle (Chen and Hochstrasser, 1995) .
The recently reported crystal structure of the 20S proteasome from the archaebacterium Thermoplasma is exceptionally informative . The barrel-shaped particle forms a central channel that widens at three positions, forming three chambers: two smaller chambers, one at each end of the channel, and a third large central chamber built by the two 13 rings. The catalytically active sites are associated with the 13 subunits and are buried deep inside the proteasome in the central chamber. The (~ rings on both ends of the particle form narrow gates with a diameter of 13/~, that would presumably only allow the passage of unfolded polypeptide chains into the proteasome. This architectu re elegantly explains why the protease, although promiscuous in its specificity, does not degrade cellular proteins constitutively: proteins must first be unfolded and threaded through the bottleneck of the proteasome before they are accessible to the catalytic sites inside the barrel. After proteolysis, it is unlikely that peptides could pass through the tightly packed outer walls of the cylinder but probably leave the proteasome either at the site of entry, as in a blender, or via the opposite gate, as in a mill. As the structure of the 20S proteasome has a perfect two-fold symmetry, both ways of peptide release seem possible.
.p~roteasomes from Thermoplasma seem to lack cleavage specificity in general. Hydrolysis by the proteasome requires a threonine residue at the amino terminus of the I~ subunit; the hydroxyl group forms the active nucleophile (SeemL~ller et al., 1995) . Interestingly, this threonine residue of eukaryotic 13 subunits is the target of a Streptomyces antibiotic called lactacystin that covalently binds to this residue, thereby irreversibly inactivating eukaryotic proteasomes (Fenteany et al., 1995) . The distance of the catalytic Sites of the first 13 ring to those of the second 13 ring corresponds roughly to the length of an extended polypeptide chain of seven to eight amino acids. It has been suggested that this "molecular ruler" may specify fragment length since proteasomes seem to generate fragments of about that size (L6we et al., 1995) .
The localization of the active sites of the I~ subunits inside the central cavity of the proteasome prevents uncontrolled proteolysis. But how is unrestrained degradation avoided when the 13 subunits are not yet assembled into the barrel? Similar to lysosomal proteases, proteasomal 13 subunits are made as inactive precursors. The lysosomal enzymes are processed and thus activated once they reach their target compartment, whereas the processing of the 13 precursors is linked to proteasome assembly (Zwickl et al., 1994) . Assembly probably begins with the formation of heptameric a rings. These rings subsequently seem to stimulate the autocatalytic removal of the pro sequence from 13 precursors and guide the assembly of processed, mature I~ subunits into ordered heptameric I~ rings stacked onto the (1 rings. Two preassembled halves (a7137) apparently then rapidly associate to form fully active 20S proteasomes.
Feeding the Proteasome
Purified 20S proteasomes can efficiently degrade small peptides, but they are inactive on intact, folded proteins (Peters, 1994) . Ubiquitin-conjugate recognition and protein unfolding are likely to be mediated by at least some of the -16 proteins that, together with the 20S proteasome, form the 26S complex. These proteins, in the size range of 35-110 kDa, assemble to separate complexes called 19S caps (reviewed by Peters, 1994; Hochstrasser, 1995) . In the presence of ATP, 19S caps can bind to both identical ends of the 20S proteasome in vitro, generating particles that have caps either on only one end or on both ends of the cylinder. Several genes for known or suspected 19S cap proteins have recently been cloned, but their cellular functions remain to be rigorously established. However, the following sequence of events that precedes the degradation of proteins inside the 20S proteasome can be hypothesized (Figure 1) .
The initial events in this pathway probably involve the recognition and anchoring of ubiquitin chains of conjugates to subunit 5, a 19S cap protein that binds ubiquitin chains (Deveraux et al., 1994) . We propose that substrates may remain virtually "chained" to this or similar receptors until enzymes of the cap have successfully unfolded segments of the protein and initiated the translocation of the polypeptide chain through the bottleneck of the 20S proteasome. Such a mechanism would enable the system to unfold selectively only those substrates that are tethered to the cap by flexible ubiquitin chains, leaving free, diffusible proteins intact. We suggest that the remarkably stable structure of ubiquitin may have evolved to withstand the unfolding forces of the enzymes of the cap, thus preventing the degradation of ubiquitin chains together with substrates. Protein unfolding is probably catalyzed by a set of similarly sized 19S cap proteins that belong to a novel family of ATPases (Dubiel et al., 1992) . Relatives of these enzymes are the Escherichia coil proteins CIpA and ClpX, which both seem to exhibit intrinsic ATPdependent chaperone activities (Wawrzynow et al., 1995) and are supposed to assemble on top of the cylindershaped CIp protease and provide specificity to the enzyme (Kessel et al., 1995) . Analogous activities could be expected for the ATPases of the 19S cap. These ATPases, possibly arranged as a ring, may contact the 20S barrel directly, as binding of the cap to the barrel is known to be ATP dependent. At a certain stage, perhaps triggered by the unfolded state of the substrate, the attached multiubiquitin chain must be removed to allow the complete trans- Figure 1 . Hypothetical Ubiquitin/Proteasome Pathway Initially, a conjugate of a substrate with multiple ubiquitin molecules (red) is formed and binds to the 26S proteasome (the 20S proteolytically active core is shown as a green cylinder; 19S caps on both ends of the 20S cylinder are schematically shown as gray cylinders). Subsequently, the polypeptide chain is unfolded and translocated into the 20S cylinder, where it is degraded. The ubiquitin chain is removed and disassembled. Peptides may be released through both openings of the proteasome.
location of the substrate into the proteasome. Yeast DOA4, a deubiquitination enzyme, is a likely candidate for this activity: mutants in this enzyme accumulate multiubiquitinated substrates that appear partially degraded (Papa and Hochstrasser, 1993) . The multiubiquitin chains freed from the substrate but probably still bound to the receptor are presumably rapidly cleaved to single ubiquitin moieties by an enzyme called isopeptidase T (Hadari etal., 1992) . Its activity is probably required to clear multiubiquitin receptors from chains and to recycle ubiquitin. Finally, the unfolded polypeptide is completely translocated into the central chamber of the proteasome, where it is degraded. Proteasomes may not only mediate the complete degradation of proteins, but also the processing of precursors into mature, active proteins. Recent evidence indicates that the p50 subunit of transcription factor NF-KB is generated by a ubiquitin/proteasome-dependent reaction that involves the degradation of the carboxy-terminal portion of its precursor (Palombella etal., 1994) . Incomplete degradation could be achieved if polypeptide chains fail to be fully translocated into the 20S barrel. This model predicts translocation arrest and protein release mechanisms. An alternative and simpler model, in which p50 is cleaved off prior to degradation of the carboxy-terminal portion of the precursor, seems more attractive. Whatever the mechanism, generation of p50 and degradation of the carboxyterminal portion of the precursor are tightly coupled, suggesting that all the activities required for this reaction are probably associated with the 26S proteasome.
More than Destruction; Antigen Processing
Antigen processing for presentation by major histocompatibility complex (MHC) class I molecules is now widely believed to involve the ubiquitin/proteasome system (reviewed by Ciechanover, 1994) . Recent studies indicate that proteasomes may be specifically altered to satisfy the requirements of this special task.
Human proteasomes probably contain only three distinct active [3 subunits; the remaining four 13 subunits of the proteasome seem to lack the active sites (Seem011er etal., 1995) . Intriguingly, all three active subunits are down-regulated by the antiviral agent interferon-7 (IFN~,), whereas three other active [3 subunits are reciprocally upregulated. Two of these up-regulated subunits, LMP2 and LMP7, are encoded bythe MHC locus. The functional consequence of the IFNT-induced replacement of apparently all active subunits of the 20S proteasome remains unclear. Conflicting evidence has been presented as to how the cleavage site specificity might be affected. Relevant changes in the characteristics of the generated peptides are indeed expected, as cells from mice deficient for either LMP2 or LMP7 show significant defects in the presentation of certain antigens (Fehling etal., 1994; Van Kaer etal., 1994) . A reasonable possibility is that peptides generated by remodeled proteasomes may be tailored--in respect to their size and sequence--to the specificities of peptide transporters, MHC molecules, or both.
Proteasomes seem to undergo additional changes upon IFN~, induction: two related proteins, PA28~ and PA2813, are coordinately induced and assemble into an oligomeric ring-shaped particle called the PA28 activator (Ahn etal., 1995) . PA28 can bind to both ends of the 20S proteasome and can accelerate the rate of hydrolysis of peptides. Since 19S caps and PA28 activators compete for the same sites at the 20S barrel, asymmetric proteasomes, furnished with a 19S cap on one end and an activator on the other, may exist. How PA28 activates proteasomes is not known, but it may directly influence catalysis by inducing favorable conformational changes in the 13 subunits or may perhaps accelerate proteolysis by clearing the proteasome of proteolytic debris.
Conclusions
The structure of the cell's protein degradation machine and its mode of action resemble that of the mills, grinders, and slicers found in kitchens. These comparatively simple machines can be manipulated in three ways: by exchanging blades with different shapes; by setting the speed of the rotating blades; and by adjusting the force that pushes the substrate through the machine. Proteasomes may be controlled by similar parameters: exchanging 13 subunits may affect the cleavage site specificity; by raising the activity of [3 subunits, e.g., through protein modification, smaller fragments may be generated; and increasing the activity of the ATPases may accelerate protein breakdown but may yield larger rather than smaller peptides. Since many proteasomal genes have been cloned, these ideas can now be tested.
